PR-Section 8 and 9

SUTENT

C.P. PHARMACEUTICALS INTERNATIONAL C.V.

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9

PTO Form 1963 (Rev 5/2006)
OMB No. 0651-0055 (Exp 07/31/2018)

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9


The table below presents the data as entered.

Input Field
Entered
REGISTRATION NUMBER 2948764
REGISTRATION DATE 05/10/2005
SERIAL NUMBER 76388649
MARK SECTION
MARK SUTENT
ATTORNEY SECTION (current)
NAME Katrina Edge
FIRM NAME Pfizer Inc.
INTERNAL ADDRESS Trademarks Group
STREET 235 E. 42nd St.
CITY New York
STATE New York
POSTAL CODE 10017
COUNTRY United States
PHONE 2127334053
FAX 2125732273
EMAIL deadlinesipnyo@pfizer.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER T111743
ATTORNEY SECTION (proposed)
NAME Katrina Edge
FIRM NAME Pfizer Inc.
INTERNAL ADDRESS Trademarks Group
STREET 235 E. 42nd St.
CITY New York
STATE New York
POSTAL CODE 10017
COUNTRY United States
PHONE 212-733-4053
FAX 212-573-2273
EMAIL deadlinesipnyo@pfizer.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER T111743-SUTENT
OTHER APPOINTED ATTORNEY Richard A. Friedman Tiffany Trunko, Heather A. McDonald, Seana Smith, Katrina Edge, and Michelle Farber.
CORRESPONDENCE SECTION (current)
NAME Katrina Edge
FIRM NAME Pfizer Inc.
INTERNAL ADDRESS Trademarks Group
STREET 235 E. 42nd St.
CITY New York
STATE New York
POSTAL CODE 10017
COUNTRY United States
PHONE 2127334053
FAX 2125732273
EMAIL deadlinesipnyo@pfizer.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER T111743
CORRESPONDENCE SECTION (proposed)
NAME Katrina Edge
FIRM NAME Pfizer Inc.
INTERNAL ADDRESS Trademarks Group
STREET 235 E. 42nd St.
CITY New York
STATE New York
POSTAL CODE 10017
COUNTRY United States
PHONE 212-733-4053
FAX 212-573-2273
EMAIL deadlinesipnyo@pfizer.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER T111743-SUTENT
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
GOODS OR SERVICES pharmaceutical preparation for the prevention and treatment of cancer
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN0-1481689621-20150507144326940720_._SUTENT.pdf
       CONVERTED PDF FILE(S)
       (3 pages)
\\TICRS\EXPORT16\IMAGEOUT16\763\886\76388649\xml2\S890002.JPG
        \\TICRS\EXPORT16\IMAGEOUT16\763\886\76388649\xml2\S890003.JPG
        \\TICRS\EXPORT16\IMAGEOUT16\763\886\76388649\xml2\S890004.JPG
SPECIMEN DESCRIPTION Patient Medication Guide identifying product and provided at time of subscription
OWNER SECTION (current)
NAME C.P. PHARMACEUTICALS INTERNATIONAL C.V.
STREET 235 EAST 42ND STREET
CITY NEW YORK
STATE New York
ZIP/POSTAL CODE 10017
COUNTRY United States
LEGAL ENTITY SECTION (current)
TYPE limited partnership
LEGAL ENTITY SECTION (proposed)
TYPE limited partnership
STATE/COUNTRY WHERE LEGALLY ORGANIZED Netherlands
PAYMENT SECTION
NUMBER OF CLASSES 1
NUMBER OF CLASSES PAID 1
SUBTOTAL AMOUNT 400
TOTAL FEE PAID 400
SIGNATURE SECTION
SIGNATURE /kedge/
SIGNATORY'S NAME Katrina Edge
SIGNATORY'S POSITION Senior Corporate Counsel [MA bar member]
DATE SIGNED 05/07/2015
SIGNATORY'S PHONE NUMBER 212.733.4053
PAYMENT METHOD DA
FILING INFORMATION
SUBMIT DATE Thu May 07 14:51:11 EDT 2015
TEAS STAMP USPTO/S08N09-XXX.XXX.XX.X
X-20150507145111466003-29
48764-5305d867ed476d1835f
9b6671b76c2ebfffe27587b0f
cea9aa51b5774eb7279ca-DA-
1002-20150507144326940720



PTO Form 1963 (Rev 5/2006)
OMB No. 0651-0055 (Exp 07/31/2018)


Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9


To the Commissioner for Trademarks:

REGISTRATION NUMBER: 2948764
REGISTRATION DATE: 05/10/2005

MARK: SUTENT

The owner, C.P. PHARMACEUTICALS INTERNATIONAL C.V., a limited partnership legally organized under the laws of Netherlands, having an address of
      235 EAST 42ND STREET
      NEW YORK, New York 10017
      United States
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.

For International Class 005, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registration for this specific class: pharmaceutical preparation for the prevention and treatment of cancer ; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) Patient Medication Guide identifying product and provided at time of subscription.

Original PDF file:
SPN0-1481689621-20150507144326940720_._SUTENT.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3
The registrant's current Attorney Information: Katrina Edge of  Pfizer Inc.
      Trademarks Group
      235 E. 42nd St.
      New York, New York (NY) 10017
      United States
The docket/reference number is T111743.

The registrant's proposed Attorney Information: Katrina Edge of  Pfizer Inc.
      Trademarks Group
      235 E. 42nd St.
      New York, New York (NY) 10017
      United States
The docket/reference number is T111743-SUTENT.
The Other Appointed Attorney(s): Richard A. Friedman Tiffany Trunko, Heather A. McDonald, Seana Smith, Katrina Edge, and Michelle Farber..

The phone number is 212-733-4053.

The fax number is 212-573-2273.

The email address is deadlinesipnyo@pfizer.com.
The registrant's current Correspondence Information: Katrina Edge of  Pfizer Inc.
      Trademarks Group
      235 E. 42nd St.
      New York, New York (NY) 10017
      United States
The docket/reference number is T111743.

The registrant's proposed Correspondence Information: Katrina Edge of  Pfizer Inc.
      Trademarks Group
      235 E. 42nd St.
      New York, New York (NY) 10017
      United States
The docket/reference number is T111743-SUTENT.


The phone number is 212-733-4053.

The fax number is 212-573-2273.

The email address is deadlinesipnyo@pfizer.com.

A fee payment in the amount of $400 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.

Declaration


Section 8: Declaration of Use and/or Excusable Nonuse in Commerce
Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods/services identified above, as evidenced by the attached specimen(s) showing the mark as used in commerce.


The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of this submission, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Section 9: Application for Renewal
The registrant requests that the registration be renewed for the goods/services/collective organization identified above.


Signature: /kedge/      Date: 05/07/2015
Signatory's Name: Katrina Edge
Signatory's Position: Senior Corporate Counsel [MA bar member]
Signatory's Phone Number: 212.733.4053

Mailing Address (current):
   Pfizer Inc.
   235 E. 42nd St.
   New York, New York 10017

Mailing Address (proposed):
   Pfizer Inc.
   235 E. 42nd St.
   New York, New York 10017

Serial Number: 76388649
Internet Transmission Date: Thu May 07 14:51:11 EDT 2015
TEAS Stamp: USPTO/S08N09-XXX.XXX.XX.XX-2015050714511
1466003-2948764-5305d867ed476d1835f9b667
1b76c2ebfffe27587b0fcea9aa51b5774eb7279c
a-DA-1002-20150507144326940720

PR-Section 8 and 9 [inode/x-empty]